Abstract | BACKGROUND: METHODS AND RESULTS: CONCLUSIONS: Primary AML cells express mesothelin but SS1(dsFv)PE38 is not active in killing these cells. Other approaches that utilize mesothelin as a target might be more effective and should be tested against AML cells.
|
Authors | Daniel Steinbach, Masanori Onda, Astrid Voigt, Kristin Dawczynski, Susan Wittig, Raffit Hassan, Bernd Gruhn, Ira Pastan |
Journal | European journal of haematology
(Eur J Haematol)
Vol. 79
Issue 4
Pg. 281-6
(Oct 2007)
ISSN: 0902-4441 [Print] England |
PMID | 17803679
(Publication Type: Journal Article)
|
Chemical References |
- Antibodies, Monoclonal
- GPI-Linked Proteins
- Immunotoxins
- Membrane Glycoproteins
- Neoplasm Proteins
- SS1(dsFv)PE38
- Mesothelin
|
Topics |
- Adolescent
- Antibodies, Monoclonal
(pharmacology, therapeutic use)
- Blotting, Western
- Child
- Child, Preschool
- Drug Delivery Systems
- Drug Resistance, Neoplasm
- Drug Screening Assays, Antitumor
- Female
- GPI-Linked Proteins
- Gene Expression Regulation, Leukemic
(drug effects)
- Humans
- Immunohistochemistry
- Immunotherapy
- Immunotoxins
(pharmacology, therapeutic use)
- Infant
- Leukemia, Myeloid, Acute
(genetics, immunology, metabolism, pathology, therapy)
- Male
- Membrane Glycoproteins
(antagonists & inhibitors, biosynthesis)
- Mesothelin
- Neoplasm Proteins
(antagonists & inhibitors, biosynthesis)
- Reverse Transcriptase Polymerase Chain Reaction
|